Cancer strategy 2023-2033: equalities (records) impact assessment

5. Decision making and monitoring

Identifying and establishing any required mitigating action

Have positive or negative impacts been identified for any of the equality groups?

Any impacts identified are positive; no negative impacts have been identified

Is the policy directly or indirectly discriminatory under the Equality Act 2010? [28]?

No

If the policy is indirectly discriminatory, how is it justified under the relevant legislation?

N/A

If not justified, what mitigating action will be undertaken?

N/A

Describing how Equality Impact analysis has shaped the policy making process

The new cancer strategy follows on from the current national cancer plan: Recover and redesign: cancer services – action plan. However, considerations of the issues in the Equality Impact analysis has influenced some of the priorities and actions within the policy, particularly in relation to the Eradicating Inequalities ambition.

Monitoring and Review

Governance and direction of the strategy will be overseen by the Scottish Government, with a national oversight group owning the strategy and associated action plans, as well as responsibility for reviewing progress. Ownership of actions will vary from national to regional and local levels. The integration and delivery of the action plans will be the responsibility of the Health Boards.

A monitoring and evaluation plan is being developed to track delivery of the ambitions within the strategy and related outcomes, across the strategy and accompanying action plans’ lifetime.

We will also continue to monitor developments taking place in other parts of the UK and elsewhere to ensure that we have a culture of continuous learning and development.